Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HeroMD SURGE
- Development stage
- Unknown
- Lead developer
- Cured Med
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Buccal, Oral, Sublingual
01
Overview
HeroMD SURGE is a compounded prescription medication developed and marketed by HeroMD (operated by Cured Med, LLC) for the treatment of erectile dysfunction (ED) in adult men. Formulated as an orally disintegrating tablet (ODT) for on-demand use, it combines sildenafil (80 mg), a phosphodiesterase type 5 (PDE5) inhibitor that increases blood flow to the penis, with Pycnogenol (50 mg), a French maritime pine bark extract that supports nitric oxide production and vascular circulation. The ODT format is designed to dissolve in under 15 minutes, allowing for rapid mucosal absorption and onset of action within 30 to 60 minutes, bypassing the gastrointestinal tract. HeroMD SURGE is prescribed through the HeroMD telehealth platform and prepared by licensed 503A compounding pharmacies.
- Brand names
- HeroMD SURGESurge
- Other names
- sildenafil + pycnogenol
02
Targets
NOS3 (eNOS)PDE1 (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase)PDE5 (Phosphodiesterase 5A)PDE6 (Phosphodiesterase 6)
Beyond the preview
Go deeper on HeroMD SURGE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HeroMD SURGE.